August 2017 - Volume 23 - Issue 8 - Contributor Index

Serum Adalimumab Levels Predict Successful Remission and Safe Deintensification in Inflammatory Bowel Disease Patients in Clinical Practice

Aguas Peris, Mariam; Bosó, Virginia; Navarro, Belén; More

Inflammatory Bowel Diseases . 23(8):1454-1460, August 2017.

Clinical Outcomes of Golimumab as First, Second or Third Anti-TNF Agent in Patients with Moderate-to-Severe Ulcerative Colitis

Taxonera, Carlos; Rodríguez, Cristina; Bertoletti, Federico; More

Inflammatory Bowel Diseases . 23(8):1394-1402, August 2017.

Colonic Phenotypes Are Associated with Poorer Response to Anti-TNF Therapies in Patients with IBD

Yoon, Soon Man; Haritunians, Talin; Chhina, Sultan; More

Inflammatory Bowel Diseases . 23(8):1382-1393, August 2017.